Honglin Chen

机构：Guangzhou University of Chinese Medicine, Fujian Medical University, Anhui University, Chinese University of Hong Kong, Nantong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Hong Kong Science and Technology Parks Corporation, China North Industries Group Corporation (China), Jining Traditional Chinese Medicine Hospital, Pantarei Design (China), Imperial College London, Nomura Research Institute, University of Hong Kong · ORCID：0000-0001-5108-8338

发表论文 722 篇 · 总被引 48688 次 · h-index 96

代表论文

• Site-specific N6-methyladenosine fine tunes CTCF/cohesin-defined enhancer-promoter interactions and oncogenic transcription program (2026 · Research Square)
• Generation of Nasal Cell‐Derived Human Alveolar Organoids and Organoid‐Macrophage Assembloids for in Vitro Lung Modeling (2026 · Advanced Science)
• A Flexible Pressure/TemperatureSensor Based on CNTs/PEDOT:PSS/PVA/SiliconeRubber Composites for Motion Recognition and Battery Temperature Monitoring (2026 · ACS Applied Nano Materials)
• ComparativeAnalysis of Data Processing Tools forMass Spectrometry Proteomics in Cardiovascular Research (2026 · Journal of Proteome Research)
• Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes (2026 · Journal of Virology)
• Cattle and human organoids reveal 2.3.4.4b H5N1 cross-species transmission potential and neuraminidase-specific neutralizing antibodies in humans (2026 · Nature Communications)